CHI3L1 and glioblastoma: To further address the extent of mesenchymal reprogramming in these tumors, immunofluorescence analysis was used to detect YKL-40 (CHI3L1), a marker of the mesenchymal subtype of glioblastoma and an indicator of cell differentiation toward an invasive phenotype [22, 23].